Deep brain stimulation of the subthalamic nucleus reduces antiparkinsonian medication costs.

@article{Charles2004DeepBS,
  title={Deep brain stimulation of the subthalamic nucleus reduces antiparkinsonian medication costs.},
  author={P. David Charles and Bimal B Padaliya and William J Newman and Chandler E. Gill and Cassondra D Covington and John Y. Fang and S. Annie So and Michael G Tramontana and Peter E. Konrad and Thomas. L. Davis},
  journal={Parkinsonism & related disorders},
  year={2004},
  volume={10 8},
  pages={475-9}
}
This study reports a retrospective analysis of 16 patients to determine changes in medication costs associated with deep brain stimulation of the bilateral subthalamic nucleus (DBS B-STN). Antiparkinsonian medication (APMED) costs were evaluated pre- and post-operatively at 1 and 2 years, based on prescribed dosages. After treatment with DBS, patients experienced a 32% reduction in APMED costs after 1 year and a 39% reduction after 2 years. Hypothetical projections of total potential savings… CONTINUE READING
15 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

Similar Papers

Loading similar papers…